Bacterin licenses Osteotech IP
This article was originally published in Clinica
Executive Summary
Bacterin International, which develops bioactive coating technology for medical devices, transplants and tissue engineering, has licensed patents from Osteotech relating to flowable demineralised bone powder compositions. The non-exclusively licensed rights will be used by Belgrade, Montana-based Bacterin in its transplant development programme. It believes its coating technologies could be beneficially applied to allografts to help reduce bacterial adhesion. The two patents in question underlie Osteotech's Grafton DBM line of tissue grafts.